ALS Disrupt provides a unique experience within the global ALS ecosystem that brings key opinion leaders together to have candid conversations on important and timely topics in front of an audience, rather than in individual conversations, with the goal of collectively tackling complex issues and exploring novel solutions. ALS Disrupt will bring the important, serious discussions the field needs into a fun, collegial atmosphere, with the goal of accelerating impact toward a world free of ALS.

Dates: April 28 – 30, 2027
Location: Sheraton Centre Toronto Hotel, Downtown Toronto, 123 Queen St W, M5H 2M9

Join us in 2027! Registration and event details will be announced in the coming months. Until then, discover what ALS Disrupt is all about and read recaps from previous meetings here.

Registration

Registration for ALS Disrupt 2027 will open soon. 

Registration is available on a first-come, first-served basis. We strongly encourage you to book early to secure your spot at this unique event that brings together global leaders in ALS research and care.

Due to the scientific nature of the discussions and content, this event is designed specifically for researchers, clinicians, and professionals working in the ALS field. It is not intended for a lay audience.

We recognize the importance of patient representation in shaping the future of ALS research and care. A small number of people affected by ALS will be present by invitation only, ensuring their voices are heard.

Program Highlights

2027 agenda coming soon

Moderators & Sessions

We are pleased to announce that ALS Disrupt 2027 sessions will once again be moderated by Dr. Michael Benatar, U.S., and Dr. Martin Turner, UK.

Speakers and sessions will be announced soon.

Our 2026 Sponsors

ALS Disrupt was made possible thanks to the generous support from:

Silver Sponsor

Trace Neuroscience

Silver Sponsor of ALS Disrupt

Visit website
Bronze Sponsor

Stiris Research Inc.

Bronze Sponsor of ALS Disrupt

Visit website